Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios
Crossref DOI link: https://doi.org/10.1007/s00277-017-3012-z
Published Online: 2017-05-22
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saglio, Giuseppe
le Coutre, Philipp
Cortes, Jorge
Mayer, Jiří
Rowlings, Philip
Mahon, François-Xavier
Kroog, Glenn
Gooden, Kyna
Subar, Milayna
Shah, Neil P.
Funding for this research was provided by:
Bristol-Myers Squibb (Not applicable)
License valid from 2017-05-22